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Abstract.  cDNA clones for murine 92 kD type IV 
collagenase (gelatinase B) were generated for the de- 
termination of its primary structure and for analysis of 
temporal and spatial expression in vivo. The mouse 
enzyme has 72 % sequence identity with the human 
counterpart,  the major difference being the presence of 
a  16-residue segment absent from the human enzyme. 
In situ hybridization analyses of embryonic and post- 
natal mouse tissues revealed intense signals in cells of 
the osteoclast cell lineage.  Clear expression above 
background was not observed in macrophages, poly- 
morphonuclear leukocytes, monocytes, or epithelial 
ceils which have been shown to express the gene in 
vitro in cell cultures.  Expression of the gene was first 
observed at early stage of cartilage and tooth develop- 
ment at E13,  where signals were seen transiently  in 
surrounding mesenchymal cells. At later developmen- 
tal stages and postnatally strong expression was seen 
in large cells at the surface of bones. These cells were 
presumably osteoclasts as their location correlated 
with that of TRAP positive cells. Signals above back- 
ground were not observed in a number of other tissues 
studied.  The results represent the first demonstration 
of a highly osteoclast specific extracellular proteinase. 
The results suggest that during normal development of 
embryonic organs the 92-kD type IV collagenase does 
not have a major role in basement membrane degrada- 
tion, but is rather mainly used for the turnover of 
bone matrix,  possibly as a  gelatinase required for the 
removal of denatured collagen fragments (gelatin) 
generated by interstitial  collagenase. 
T 
YPE IV coUagenases (gelatinases)  belong to a family 
of mammalian  extracellular  metalloproteinases  which 
are the products of related genes (5, 46). The metallo- 
proteinases share several  structural  and functional  proper- 
ties,  and all of them exhibit the capacity to degrade one or 
more of the molecules that constitute  the extraceUular ma- 
trix.  The enzymes are secreted as zymogens, they have a 
Zn2+-binding site,  and they are inhibited  by specific tissue 
inhibitors  of  metalloproteinases  (TIMPs) 1 (5,  46).  The 
metalloproteinase family contains  at least nine genetically 
distinct  members:  two interstitial  collagenases  which de- 
grade fibrillar collagens of types I, II, and HI (13-15), three 
stromelysins  (3, 6, 24, 43) with activity against  collagens 
with interrupted triple helices and some noncollagenous pro- 
teins,  matrilysin  (pump-l)  a  small  proteinase with a wide 
range of substrates including  fibronectin,  laminin,  casein, 
gelatin and proteoglycans  (5, 30, 47), macrophage  metallo- 
elastase with activity against elastin (38), and the 72-kD (9, 
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16, 21, 33) and 92-kD (26, 44) type IV coUagenases (gelatin- 
ases A and B, respectively)  which degrade type IV collagen 
and  denatured  collagen  (gelatin).  The  metalloproteinases 
presumably play an important role in tissue remodeling dur- 
ing embryonic development  and in other conditions  where 
matrix degradation  occurs, such as in inflammation  and tu- 
mor invasion. 
The two type IV coUagenases cleave native type IV colla- 
gen,  a specific component of basement membranes, in the 
triple-helical  region  into  1/4- and  3/4-size  fragments  and 
they possess high activity against gelatin (11, 26). Addition- 
ally, both enzymes have been shown to be able to degrade 
native type V and VII collagens.  The 72-kD type IV col- 
lagenase  has  also been shown  to cleave  type X  collagen 
which is present in cartilage (46). However, neither enzyme 
degrades type I collagen, proteoglycan, or laminin. The high 
activity against gelatin has led to the hypothesis that the type 
IV coUagenases play a role in the removal of denatured colla- 
gen fragments after cleavage of native collagen by the other 
metalloproteinases. 
The question as to why two distinct type IV collagenases 
with seemingly  identical  substrate  specifically are required 
is now beginning  to become unraveled.  It has previously 
been shown that the secretion of the two enzymes is not coor- 
dinately  regulated  in cultured cells (44, 48), and also that 
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gene expression (17, 18). In vivo both enzymes are likely to 
be important for tissue remodeling  during  embryonic mor- 
phogenesis.  Increased proteinase activity  has earlier been 
implicated  in embryonic development  (7). Using in situ hy- 
bridization,  we have recently shown that the 72-kD enzyme 
is expressed primarily in mesenehymal  cells during mouse 
development  (31). In contrast, ectodermal and endodermal 
cells, with the exception of salivary gland, generally showed 
no expression.  The high expression of the 72-kD type IV col- 
lagenase in mesenchymal cells indicates that this enzyme has 
a general role in the remodeling of extraceHular matrix, not 
only in the degradation  of the basement membrane type IV 
collagen,  but probably also in the removal of denatured pro- 
teolytic fragments  of fibrillar  collagen molecules (gelatin). 
Knowledge about the physiological role of the 92-kD type IV 
collagenase is still limited,  but it is known to be secreted by 
cultured  lung  alveolar  macrophages,  polymorphonuclear 
leukocytes, trophoblasts,  and keratinocytes  (4,  15, 22, 26, 
34). Therefore,  this enzyme might be used by macrophages 
and leukocytes for their penetration through the extracellular 
matrix and by trophoblasts  during embryonic implantation. 
The expression of the 92-kD type IV collagenase in keratino- 
cytes in vitro also suggests that it is used for the turnover of 
subepithelial  basement membranes. 
Both type IV collagenases have gained particular  attention 
for their association with invasive tumor processes indicat- 
ing that the tumor cells require the enzymes for the degrada- 
tion of basement membranes during dissemination  and for- 
marion of metastasis. A number of cultured tumor cells have 
been reported to secrete type IV collagenases,  and recently 
numerous immunostainlng  and in situ hybridization  studies 
have demonstrated activation of their genes in tumor tissues. 
Expression of the 92-kD type IV collagenase has been shown 
in maerophages located at the invading tumor front of human 
squamous cell (28) and colon carcinoma (29) by in situ hy- 
bridization and by immunostaining  in breast carcinoma (42). 
In squamous cell carcinoma expression of the 92-kD enzyme 
has also been detected in the tumor cells themselves. The ex- 
pression pattern of the 72-kD type IV collagenase is different 
in that expression,  as judged by in situ hybridization,  occurs 
in fibroblasts adjacent to the tumor front (27-29, 42), while 
the antigen is mainly localized by immunostaining  to the tu- 
mor cells at the front of the invading tumor mass (2, 25). 
To explore the physiological role of the 92-kD type IV col- 
lagenase, we have cloned the murine enzyme, determined its 
primary structure and studied its spatial  and temporal ex- 
pression during mouse development by in situ hybridization. 
Intense expression was observed in osteoclasts at sites  of 
bone formation.  Despite transient  expression  at embryonic 
days  12-13  in some mesenchymal cells, expression  above 
background was not observed in macrophages  or any other 
cells in numerous tissues studied. 
isolated  from total RNA by the Poly  A  Track mRNA Isolation System 
(Promega,  Madison, WI). 
Construction of  cDNA Clones 
The cDNA clones were generated from polyadenylated RNA using the PCR 
method. The sequence for the PCR oligonucleotide  primers were based on 
the sequence of the mouse 92-kD type IV collagenaxe gene (Munaut, C., 
P. Huhtala, P. Reponen,  and K. Tryggvason, unpublished results) and the 
RACE (rapid amplification of cDNA ends) technique (12). The first cDNA 
strand was synthesized with the Moloney murine leukemia virus (M-MLV) 
reverse transcriptase enzyme (BRL) using either specific primers or a "hy- 
brid" primer consisting of oligo(dT)  (17 bases) linked to a unique 18-base 
oligonucleotide  ("adaptor")  primer  (5'-GACTCGAGTCGACATCGATTT- 
T1TFFI-I°I'Vi'FI'I't:3  ') (12). PCR amplification  followed directly using 
the mRNA-cDNA hybrid as a template and the ~laptor primer which binds 
to the 3' end of the eDNA and the specific primer from the 5' end of the 
template.  Four overlapping cDNA clones generated with this method were 
compared by electrophoresis on an agarose gel and subcloned into the T-vec- 
tor, derived from the Bluescript plasmid (23). The cDNA clones were se- 
quenced from both strands by the dideoxynucleotide  chain termination 
method (37) with Sequenase  (USB).  Either universal primers or specific 
primers were used, and the sequence was compared to the sequence from 
genomic clones. 
Preparation of Ttssue Sections 
The embryonic age of the hybrid mice (CBA x  C57BL) was set according 
to the day of the vaginal plug, which was designated day 0. Different organs 
or whole embryos from 12-d embryos to lid postnatal mouse pups were 
dissected under a stereo microscope in PBS, fixed in 4% paraformaldehyde 
in PBS (pH 7.2) at +4°C overuight,  dehydrated and embedded in paraffin 
wax. Sections of 7 ~  thickness were placed on silanized glass slides, dried 
overnight at +37"C, and stored in tight boxes at +4°C until use. 
In Situ Hybridization 
For the preparation of RNA probes the M92KD-2 cDNA clone was cut with 
Smal and EcoRl restriction enzymes (SmaI site between nucleotides  191% 
1918, see Fig. 1) and the 323 bp fragment was cloned into pSP64 and pSP65 
plasmid vectors (Promega).  The pSP64 (sense) and pSP65 (antisense) plas- 
mid vectors were linearized with EcoR/and ~  restriction enzymes, 
respectively, and the [35S]-uridine S'-triphosphate  (+1,000 Ci/nmol, Amer- 
sham)  labeled  RNA-probes  were  transcribed using  a  transcription kit 
(Promega).  The labeled probes were precipitated with ethanol, dissolved 
in hybridization buffer, and used at 50,000-60,000 cpm/~d. The in situ hy- 
bridization  was carried out according to Wilkinson and Green (45). In brief, 
the dcparaflinized sections were pr~ated with proteinase K (Sigma Chem. 
Co., St. Louis, MO), hybridized with the labeled probes in a humid cham- 
ber overnight at 50°C,  and washed under high-strin~ncy conditions.  The 
dried slides were dipped in autoradiographic emulsion (Kodak NTB2) and 
exposed  for 10 d at 10°C.  After dcvelopiug  the film,  the sections  were 
stained with hematoxylin and mounted. 
Tartrate Resistant Acid Phosphatase Staining 
"fiu'trate  resistant acid phosphatase (TRAP) stalnin~ was performed accord- 
ing to Thompson (41). Briefly, the dcparaffiniTed slide~ were incubated in 
50 mM tartrate in acetic buffer at 37"C for 2 h. Then, the sections were 
incubated in an acid pbosphatase substrate buffer (25 % Michaelis acetate 
buffer, 0.16% pararusaniline, 0.16% NaNO2, 0.05% naphtol AS-BI phos- 
phate), pH 5.0 with 20 mM tartrate at 37"C for 60 rain, washed in distilled 
water, and mounted. 
Materials and Methods 
Isolation of  RNA 
For the preparation of cDNA, polyadanylated  RNA was isolated directly 
from cultured mouse keratinocytes and 7-d old mouse skulls and leg bones. 
The mRNA was isolated directly from cultured cells with a slight modifica- 
tion of the Fast Track RNA isolation kit method (Invitrogen).  Total-RNA 
from the 7-d old mouse tissues was first isolated by the acid guanidinium 
thiocyanate-phenol-chlomform  extraction (8) and the mRNA was further 
Results 
Nucleotide Sequence and Comparison of the Mouse 
and Human Amino Acid Sequence 
The 3152 bp sequence of the four overlapping cDNA clones 
generated in this study contained 19 bp encoding a 5' end un- 
translated region, a 2,190 bp open reading frame and 943 bp 
of a 3' end untranslated  sequence (Fig.  1). The sequence was 
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PstI SmaI  XhoI  Sinai  PstI  Pstl 
I  I  I  I  I  I  AA/~A 
I  I  I  U 
AT(:;  TGA  AATAAA  AATAAA 
-19  AUAP.C,  CT~  CU gT CC~CACC 
I  ATUA~'TC4:CT~CA~CCCCTC.CTCCT~IGCTCTCC  T~;CTTTC~CAUCT~I~C'/~CCCC~CC~AaC~T  ~C~~~T~C~T~T~TG 
.....  o  ............  ,  ....  °  ..............  ._.  ........... 
1  -  ~  L  ....  V  -  V  -  -  V  L  -  -  C  F  -  -  -  R  -  -  -  $  -  L  -  L  -  -  G  -  -  R  ....  ~--  R  ....  E  -  - 
100  ....  L  ......  ~  -  O  -  -  ~  E  .................  A  V  ..........  L  -  S 
448  C ~UUTGUCACCCCT  CACCTTCACCCC,  C~T~TACUC.ACCCC,  A~UC  UC.AC&TTG'~CATCC~UTT~~~A~~~~T~C~C~ 
150  ~  V  X  ~  L  T  ~  T  R  V  Y  ~  P  ~  A  O  I  V  I  O  F  ~  V  A  •  a  ~  O  ~  Y  P  r  D  G  K  O  •  L  L  A  ~  ~  r  ~  P  U  A  U  Y  0 
150  A  -  ?  ........  S  I~  O  ................................  P  -  I  - 
598  GGAGAT GC  C  CATT  TCC,  ACGAC GACGAGTTGTGGTCGCT  GGCCA~GCGTCGTGATCCCCR~  ~T~CAT~C~~~T~A~ 
200  G  0  A  ~  ~  0  D  D  E  L  W  ~  ~  G  X  G  V  V  I  P  T  ~  Y  ~  S  S  a  G  &  P  C  a  r  P  r  T  r  g  =  R  S  ~  S  A  C  T  •  D  ~  R 
200  ..................  V  -  -  R  r  -  -  A  D  -  -  A  .....  I  .............. 
748  A~CGAC UCCAC~CCTT  GUT  GTA~CACAACAC-CTC,  AC  TACUATAAUGACGUC.AAATTTC,~T  ~T~T~~~~T~C~  C~T~C~  ~ 
250  ~  0  ~  T  1=  w  c  S  T  T  A  O  ~  O  K  O  ~  X  r  ~  r  C  •  s  ~  R  L  Y  T  ~  •  ~  ~;  ~  •  ~  g  P  C  V  F  P  r  I  r  ~  ~  ~  S 
250  s  -  -  L  .......  ~  -  -  T  -  n  R  ...........  R  0  -  -  A  O  ....  Q  .....  O  -  Q  -  - 
300  .....  o  ................  R  -  -  -  r  ......  ~  -  S  -  -  M  ........... 
35O  -  -  T  ....  •  -  -  T  -  -  -  •  -  -  u  .............  s  .................. 
1198  GCGCA~ GAGTTCG~CCATGCACTGGGCTTAGATCATTC  CAGCQTGCCGGRAGCCK~CATGTACCC~CTGTATAG~T~  C~T~T~T~TA~GTA~  G~  T~CT 
400  A  B  E  F  U  B  A  L  U  L  D  ~  S  S  V  P  E  A  L  H  Y  P  L  ~  S  T  L  E  U  F  P  L  N  K  D  D  ~  O  Q  I  O  Y  L  Y  G  R  ~  S  K  P 
400  ......................  M  -  R  l"  T  -  -  P  -  -  Jl  -  O  -  V  N  -  -  R  ~!  -  -  -  P  R  P  •  - 
1348  ¢  ACC  CAAGGCCT~  CAGCCA~CAC  CACAACTGAAC~GACRD,  CACCTCCCACTATGTGTCUCACTATACC~  ~CTA~C~~~  C~~C  = 
450  O  P  rt  P  P  &  ¢  T  T  Z  E  P  O  P  T  A  ~  P  T  t(  C  ~  T  1  P  P  ~  &  Y  P  T  V  U  ~  T  V  ~  P  T  (~  &  P  S  P  ¢~  P  T  S  l 
450  E  ....  ?  -  -  -  ~:~.~  ........  V  -  -  -  G  -  -  -  V  I1  -  S  [  .....  I~  a  - 
1498  TCAC ~T  GGC  CCTAC AGC,  C  GCC  CCCTCACCTG~CCCTAC  k~CGGCCCCTACTQCGGGCT  C~C~T~C~T~T~T~  T~TG~A~C~C~  ~TG 
500  S  F  U  P  T  U  A  P  $  P  G  P  T  A  A  P  T  A  Q  |  S  E  A  8  T  E  8  L  $  P  A  O  N  P  C  N  V  D  V  F  D  A  ~  A  E  I  Q  G  A  L 
482  T  A  ....  P  -  -  A  -  -  -  G  P  ....  P  -  T  -  T  -  V  P  -  -  -  V  -  D  A  -  -  -  N  I  .......  G  ~  Q  - 
I~48  CATTTC TTCAAGGACGGTTGG~ACTC,  GAAGTTCCTGAATCATA~AGGAAG~CCATTACkGGGCCCCTTC  ~T~ C~G~C~C~  ~  C~  ~T~AT ~  Uy~C~T~T  C 
550  ~  F  r  K  D  G  N  Y  W  K  F  L  N  H  R  G  S  P  L  Q  G  P  F  L  T  &  It  T  W  P  A  L  ¥  A  T  L  D  S  A  F  E  D  P  Q  T  K  R  V  F  F 
532  Y  L  ....  x  -  -  R  -  $  E  G  -  -  -  It  p  .....  I  -  O  X  .....  R  X  -  ~  -  V  -  -  ~  -  L  S  -  X  L  -  - 
600  r  S  U  ~  0  ~  W  V  ~  ?  U  ~  •  V  L  U  ~  It  S  ~  O  K  L  ~  ~  ~  P  ~  V  T  S  V  S  ~  L  ~  I,  ]~  ;~  P  ~  X  ^  L  ~  F  s  K  ~ 
582  .....  v  .....  A  s  .....  R  .......  A  O  -  A  0  -  T  -  A  -  R  S  U  ~  M  ....  G  R  - 
194e  GTCTGGAGATTCGATTTGAAGTCTCAGAAGGTGG&TCCCCAGA~AIWCGCGTGGATRAGG~C~  ~C~ATC~C~&TT~C  ~TG~TTC~CTG~T  I 
650  V  W  R  F  O  L  X  S  0  K  V  0  P  0  S  V  I  S  V  O  K  E  F  S  G  V  P  ~  N  $  ~  O  I  F  O  Y  0  O  K  A  Y  r  C  S  g  K  ~  F  W  R 
I;32  L  ....  V  -  &  -  H  -  -  -  R  -  A  $  E  -  -  It  H  -  P  -  -  -  L  D  T  -  -  V  -  -  -  R  E  .....  O  D  R  -  ¥  -  - 
20~8  ~GTGA~TTTC~TGAGQTGAACRA~TGGACCCTGAC~G~PD`~A~c`A~GTGGGCTAC~TGA~CTACG~CCTc~T~T~~T~T~T~~  ~ACCACC~ 
700  V  S  ~  O  ~  ~  V  N  K  V  O  P  •  V  N  0  V  D  D  V  ~  T  V  T  •  O  L  L  ~  C  P ~ 
224~  C CACCAC~GTAnACACAAACCC  C~TCC~C.~TACAGACTU~T  ~,ATCTCT'Z~T~&~~~~C~  ~T  ~T~T~ 
239t  ~A~C'~T~CC~AcCTTTTCCAC~CTAcTTT~GT~A~TCAGCTTATCT~TAGTT~CAGA~A~c~G~T~TTA~T~G~Q~TT  ~TC~  ~T~A~ 
2548  AGGCACTTC~  CGGt'T  AAACEACCTC  TCCCGACT~CCTTTTATTTATTATGTAT~TAT~T~T~A~TA~T~  C~T~T~~  ~T  ~AT~TATT~TA~CA 
2698  GTT  QCCCCTACTGGAACGTATTJ%TGTAACTATTT  CTCT  CTTACATTGGAGAACACC~  C~AT~T~T~A~T~~CTA~~T~T~  ~CT 
2848  T~T T  GCTCAGAC-ATTCTCCGT  GTCCTQTA~ATCTGCTGRJU%CCAGACCCCAGACTCCTCTCTCTC~CGAGAQTC~C~T~  ~~~ATG~  A~ 
2998  GTCTGTGCGTTATGGT  TCAQG~AGACTGT~TCCTCCC~GTGAG~TGACCCCTCAf~CTGG~C~T~T~C~T~T~T~T~T~TA~T~c~~ 
3148  A 
Figure 1.  Partial map of the mouse 92-kD type IV collagenase cDNA clones, nucleotide sequence, and predicted amino acid sequence. 
On top, overlapping eDNA clones and p~u'tial restriction map. Below, nucleotide and amino acid sequences. The first line shows the nucleo- 
tide sequence starting from the transcription  initiation site. The second line shows the predicted amino acid sequence. The third line shows 
the amino acid sequence of the h-m:~n preproenzyme (44) with identical residues depicted by (-)  and differing  residues by one-letter 
code. Missing amino acids or nucleotides are illustrated  by shaded boxes. The numbering of amino acids is shown starting from the first 
residue of the prepropeptide. The open box depicts the region of the cDNA used for the in situ hybridization probe and the polyadenylation 
signals (AATAAA) are underlined. The nucleotide sequence reported in this paper has been submitted to the GenBank='/EMBL  Data Bank 
with accession number Z27231. 
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(Munaut, C., P. Huhtala, P. Reponen, and K. Tryggvason, 
unpublished) and the mouse eDNA sequence reported while 
this work was in progress (40).  The DNA sequence eluci- 
dated in the present study differs slightly from the reported 
sequence in that there are two differences in the predicted 
amino acid sequence. In the translated sequence the codon 
for residue 514 is GCC for alanine, not CCC for proline, and 
the codon for residue 711 is CCT for proline, not CAT for 
histidine.  Furthermore, the present sequence contains an 
ACA codon for threonine 278,  instead of ACG, the ACT 
codon for threonine 459 instead of ACA and the GAT codon 
for aspartate 654 instead of GAC. The two differences ob- 
served in the untranslated sequences were a lack of a C at 
position -5 in the 5' end UTR and base 2607 was T not A. 
The presently elucidated eDNA sequence was identical to 
the exon sequences in the gene (Munaut, C., P. Huhtala, P. 
Reponen, and K. Tryggvason, unpublished). However,  the 
differences from the reported sequence (40) could be due to 
variations within species. 
The mouse amino acid sequence contains several differ- 
ences from the human enzyme. The most striking difference 
is the presence of a  16-residue  segment (residues 481--496, 
Fig. 1) absent from man. This segment is located in the mid- 
die of 48-residue sequence which distinguishes the primary 
structure of the human 92-kD type IV collagenase. The se- 
quence is contained in exon 9. Additionally, the human en- 
zyme lacks amino acid residues corresponding to Set-38, 
and residues 459-460 and 708-714. 
Localization of 92 kD ~  IV CoUagenase Expression 
during Mouse Development by In Situ Hybridization 
The in situ hybridization analyses revealed a remarkably cell 
and stage specific expression pattern in both embryonic and 
postnatal mouse tissues. No expression was observed in any 
tissues before El2 (data not shown). All control sections hy- 
bridized with the sense probes were also negative (data not 
shown). 
In El2  embryos intense expression was detected in the 
limb buds in the mesenchymal cells around the developing 
cartilages of radius and ulna (Fig. 2, a and b). Similar stain- 
ing pattern was detected around the incisor tooth germs in 
the El3 mandible (Fig. 3 a). This expression was quite in- 
tense and uniform in several layers of condensed mesen- 
chymal cells which were TRAP negative (data not shown). 
However, the expression was transient and it appeared to be 
restricted to early stages of development. No expression was 
observed in any other tissues at this stage. 
In El4 embryos intense expression of 92 kD type IV col- 
lagenase was detected in single cells in the center of  the max- 
illary and mandibular processes (Fig. 3, b-e). During ad- 
vancing embryonic development and postnatally the number 
of positive cells increased and they were localized through- 
out the mandibular and maxillary bones which form by in- 
tramembranous ossification (Fig. 4  a).  Large numbers of 
positive cells were localized at the  site of endoehondral 
ossification  beneath  the  condylar  cartilage  (Fig.  4  b). 
Numerous positive cells were localized at the bone surface 
around the growing tooth germs where bone resorption takes 
place (Fig. 4, c-e). 
In  the  developing  forelimbs  single positive  cells  were 
localized in the perichondrium of the digits at El5 (Fig. 2, 
c and d). Similarly, in El6 forelimbs positive cells were pres- 
ent at many sites in the perichondrium/periosteurn and in ad- 
dition large aggregates of single positive cells were apparent 
in the growth plates at sites of endochondral ossification 
(Fig. 2, e and  f). All other tissues in the limbs such as skin 
and muscle were devoid of signals above sense probe back- 
ground. 
Adjacent sections of the jaws and bones were analyzed 
with enzyme histochemical staining for TRAP which is a 
marker of osteoclasts. The distribution of TRAP positive 
cells adjacent to the bone closely resembled that of  the single 
cells expressing 92 kD type IV collagenase (Fig.  5). 
Expression of 92 kD type IV collagenase was examined in 
a variety of other tissues at different stages during develop- 
ment and postnatally. In the embryo expression was detected 
around the clavicle of an El4 embryo (Fig. 6, c and d) while 
signals above background level  were not detected in skin, 
mammary gland, or kidney (Fig. 6).  Also, salivary gland 
which expresses the 72-kD  type IV collagenase (31) and 
brain were negative (not shown). After birth signals were 
seen  in the bone marrow of adult mice,  presumably os- 
teoclasts (Fig.  7,  e  and f).  However,  signals above back- 
ground were not observed postuatally e.g., in lung, heart, or 
intestine. 
Discussion 
The results of this in situ hybridization study showing ex- 
pression of 92 kD type IV collagenase in mesenchymal cells 
around early development of cartilage and in single cells lin- 
ing embryonic and postnatal bone, sharply contrast with cur- 
rent views on its tissue distribution and biological role. In 
previous studies 92 kD type IV collagenase activity has been 
shown to be secreted by cultured peripheral blood polymor- 
phonuelear leukocytes and monocytes, as well as by cytotro- 
phoblasts and alveolar macrophages in vitro (4, 5, 15, 20, 22, 
26, 44). These cells, which are capable of  migrating through 
connective tissue barriers, have been speculated to use the 
enzyme for the degradation of  basement membrane and stro- 
real collagens. The demonstration of 92 kD type IV col- 
lagenase expression in cultured keratinocyt~s (34) also sug- 
gested that the enzyme is normally needed for basement 
membrane turnover. 
The present in situ hybridization results indicate different 
physiological roles for the 92-kD type IV collagenase than 
previously anticipated.  Thus,  during embryonic develop- 
ment and until 9 d postnatally, high expression was observed 
in osteoclasts, while it could not be detected above back- 
ground levels in any epithelial cells of skin, lung, intestine 
or kidney, and not either in subepithelial mesenchymal cells. 
Therefore, this enzyme is not likely to play a major role in 
the normal turnover of basement membranes. Furthermore, 
clear signals were not observed in tissues usually rich in 
monocytes/macrophages such  as  liver,  lung  or  intestine, 
even at 9 d postuatally. Only in bone marrow scattered cells, 
possibly representing the monoeyte/macrophage/osteoclast 
lineage,  were positive.  Our  interpretation of the  present 
results is that the biological function of 92 kD type IV col- 
lagenase during embryogenesis is primarily to degrade the 
extracellular matrix around the growing cartilage and in the 
developing bone. These tissues are rich in type I, II, and IH 
collagens and they also contain collagen types V, VI, VIII, 
The Journal of Cell Biology, Volume 124,  1994  1094 Figure 2. Expression of 92 kD type IV collagenase during limb development. (A and B) El2 fore limb. The mesenchymal cells around 
the radius and ulna show expression of 92 kD type IV collagenase. (C and D) In the El5 fore limb expression is detectable around the 
cartilage (white arrow). Single cells in the periehondrium  of the metacarpal cm~age as well as at the tips of the digits intensely express 
92 kD type IV collagenase. In the El6 fore limb (E and F), the expression of 92 kD type IV collagenase is very intense in the ossifying 
regions of the long bones.  Also the perichondrium  and the periosteum  show some expression (arrows). (A, C, and E) bright field; (B, 
D, and F) dark field. Bar, 400 #m. 
IX, X, XI, and XII, but not the basement membrane type 
IV collagen (for review see 36).  Although the actual sub- 
strate of the  92  kD type IV collagenase is  not  known,  it 
seems plausible that the enzyme acts as a gelatinase involved 
in  the  removal of denatured  collagen  fragments  (gelatin) 
formed by  the  action  of interstitial  coUagenases  that  are 
considered the only enzymes capable of degrading collagen 
fibres which contain interstitial collagens. Once cleaved into 
Reponen et el. Expression of 92-kD Type IV Collagenase  1095 The Journal of Cell Biology, Volume 124,  1994  1096 Figure 4. Expression of 92 kD type IV collagennse during fetal and posmatal development of the jaw. (A) In the E18 man&'ble, the 92-kD 
type IV collagenase gene expression  is intense throughout the developing bone of the mandible.  The developing teeth are completely nega- 
tive.  (B) Higher magnification  of the condylar process.  (D and E) 11 d postnatal mandible  with incisor tooth. The expression in the bone 
is most intense at the resorptive surface around the growing tooth germ. (C) Magnification  of the tip of the incisor.  The area of the bone 
through which the incisor is about to erupt shows especially intense 92 kD type IV collagenase expression,  c, condylar process; i, incisor; 
m, molar; Mc, Meckers cartilage.  (A, B, C, and D) bright field;  (E) dark field of D. Bar,  200 #m. 
Figure 3.  Localization of 92 kD type IV collagenase expression  by in sire hybridization in the head of El3 (A) and El4 (B, C, D, and 
E) mouse embryos. (A) Transverse  section through the anterior part of the lower jaw. Intense expression is seen in the mesenchyme around 
the incisor tooth germ. (B and C) Sagittal  section of El4 anterior embryo hybridized with antisense  (B) and control sense (C) probes. 
All tissues are negative for 92 kD type IV collagenase,  except in the central areas in the upper and lower  jaw where spots of strong expression 
can be seen. The spots are localized  to single cells in the developing jaw bones (D and E) in the area where the first ossification  can be 
seen at 15 d p.c.  (A and D) bright field;  (B, C, and E) dark field,  i, incisor; t, tongue. Bar, 400/~m. 
Reponen et al. Expression of 92-kD Type IV CoUagenase  1097 Figure 5. Identification of osteoclasts in the fore limb by TRAP staining and colocalization with 92 kD type IV collagenase expression. 
(A and D) TRAP-stained osteoclasts (red) are evident in the epiphyseal plate in the bone of  2-wk-old mouse forelimb. (B) In situ hybridiza- 
tion of an adjacent section to A shows intense expression of 92 kD type IV collagenase in cells with similar distribution as osteoclasts 
(arrows). (C and F) Negative in situ hybridization control of an adjacent section to B with sense probe. D, E, and F are magnifications 
of A, B, and C, respectively, b, bone; hc, hypertrophic chondroeytes. Bar, 100 #m. 
two  1/4 and 3/4 size triple-helical fragments, the collagen 
fragments denature at body temperature and can subsequently 
be degraded further by the gelatinases. 
The highly restricted spatial and temporal expression indi- 
cates two major functions of the 92-kD type IV collagenase 
during embryonic development. First, at El2 and El3, the 
earliest stages of expression, signals were only observed in 
TRAP negative mesenchymal cells around the developing 
cartilages and tooth germs.  This expression was  restricted 
only to early stages of development suggesting that the en- 
zyme functions in the removal of gelatin at the growing end 
of the cartilage and tooth allowing their rapid growth. Sec- 
ond, the localization of expression to cells on the surface of 
the developing bones from El4 onwards implies a  specific 
The Journal of Cell Biology, Volume  124, 1994  1098 Figure 6. Expression of  92 kD 
type IV coUagenase in various 
tissues during mouse develop- 
ment. (A and B) El4 skin with 
hair  follicle,  (C and D)  El4 
clavicula,  (E  and  F)  El6 
mammary gland,  (G and H) 
El8  kidney  hybridized  with 
antisense probe, and (I and J) 
E  18 kidney hybridized  with 
control sense probe. Skin with 
hair follicle, kidney, and mam- 
mary gland  do not  show ex- 
pression of the 92-kD type IV 
collagenase gene above sense 
control  background.  In  the 
clavicula,  one of the earliest 
ossification  centers,  spots  of 
expression  are  seen  in  the 
periosteum which presumably 
represent  osteoclasts.  (A,  C, 
E, G, and I) bright field; (B, 
D, E H, and J) dark field. Bar, 
200 ~m. 
role of the enzyme in the resorption of bone, presumably in 
the removal of gelatinous polypeptides. The localization of 
these positive cells showed close correlation with osteoclasts 
which  were localized in  adjacent  sections by staining  for 
TRAP which is generally considered a marker of osteoclasts 
(41).  Our preliminary observations (unpublished)  in older 
bones indicate that TRAP positivity in the osteoclasts does 
not always correlate with 92 kD type IV collagenase expres- 
Reponcn et al. Expression of 92-kD Type IV Collagenase  1099 Figure  7.  Expression  of  92  kD 
type  IV  collagenase  in  various 
postnatal  and  adult  tissues.  (A 
and B)  9D postnatal  lung, 
(C  and  D )  9D  postnatal  heart, 
(E  and  F)  adult  bone  marrow, 
(G  and  H)  adult  intestine.  The 
lung,  heart,  and intestine  do 
not show signals  for 92 kD 
type  IV coUagenase  gene  ex- 
pression  above  sense  control 
background  (not  shown).  The 
bone marrow (E  and  F) from 
the adult  femur shows  some 
single cells expressing the 92- 
kD type IV coUagenase  gene. 
(A, C, E, and G) bright field; 
(B, D, F,, and H) dark field. 
Bar, 200 gm. 
sion. Hence, the 92-kD enzyme expressing cells may repre- 
sent only a subpopulation of cells in the osteoclast cell lin- 
eage. Metalloproteinase activity has been suggested to occur 
in osteoclasts (10) but our study is the first to demonstrate 
the expression of a metalloproteinase highly specific for os- 
teoclasts. Although it has not yet been demonstrated, it is 
likely that osteoclasts secrete interstitial collagenases which 
are  presumably  essential  for  dissolution of the  collagen 
fibrils. Lysosomal cathepsins have also been proposed to par- 
ticipate in the extracellular degradation of bone matrix (10). 
Surprisingly, with the exception of bone marrow, clear ex- 
pression of  the 92-kD type IV collagenase above background 
was not observed in tiffs study in embryonic or postnatal tis- 
sues normally containing macrophages. The question there- 
fore  rises,  whether  findings  showing  that  macrophages, 
monocytes, and polymorphonuclear leukocytes secrete the 
enzyme in vitro have any relevance to the situation in vivo. 
It  is  possible  that  although  transcripts  are  absent  from  mac- 
rophages of  normal tissues,  they  possess  the  potential  to  ex- 
press  the  92-kD type  IV coLlagenase  e.g.,  upon stimulation 
by  cytokines.  In  fact,  we  have  shown  by  in  situ  hybridization 
that  macrophages located  adjacent  to invading  cells  of  hu- 
man tumors of  skin  (28),  colon (29),  and ovary (I)  express 
the  gene.  The  enzyme  antigen  has  also  been  localized 
specifically to  macrophages  in  human  breast  cancer  by 
monoclonal antibodies (42).  Furthermore, there is evidence 
that the 92-kD type IV collagenase is involved in other patho- 
logical processes such as periodontal inflammation (19, 39) 
and wound healing (35)  where the activity may be present 
in macrophages.  Hence,  the absence of signals in macro- 
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simply  reflect  the quiescent state  of the cells.  Since  os- 
teoclasts,  like macrophages,  have their origin in hematopoi- 
eric cells, it can be speculated that cells of the hematopoietic 
cell lineage can in certain  situations be induced to express 
the 92-kD type IV collagenase gene. The localiTation of 92- 
kD type IV collagenase mRNA by in situ hybridization in tu- 
mor cells of human squamous cell carcinoma  (28), but not 
of colon cancer (29), also indicates that the gene may be in- 
duced in malignant  transformation of some tissues. 
Several studies have indicated that the 92-kD type IV col- 
lagenase is critical for the invasion of cytotrophoblasts  dur- 
ing embryonic  implantation.  Presence of the enzyme has 
been shown in these cells by zymography and their invasion 
into extracellular matrix could be inhibited by specific anti- 
bodies (4, 20). We have also shown by in situ hybridization 
analysis  that  the 92-kD  type  IV  collagenase  gene  is  ex- 
pressed solely in the trophoblast population (Reponen, P., C. 
Sahlberg,  I.  Thesleff,  and  K.  Tryggvason,  unpublished 
data).  These observations suggest that the 92-kD type IV 
collagenase  also has a key  role in the degradation  of the 
maternal extracellular matrix by the extraembryonic tropho- 
blast cells. 
In conclusion, the results of the present study suggest that 
during  normal  morphogenesis,  the  92-kD  type  IV  col- 
lagenase  is mainly secreted  by osteoclasts where it is used 
for bone remodeling.  However, the enzyme can also be in- 
volved in physiological tissue remodeling by extraembryonic 
trophoblasts  during embryonic  implantation  and in patho- 
logical  states  such  as  tumor  invasion  and  inflammation 
where it may be secreted  by macrophages.  The expression 
pattern of the 92-kD type IV collagenase differs completely 
from that of the 72-kD enzyme the expression of which has 
been shown to be widely distributed mainly in mesenchymai 
tissues during development of all organs (31). The 72-kD en- 
zyme is intensely expressed in osteoblasts 02),  but we do 
not know whether it is expressed by osteoelasts also. This 
question can be studied in isolated osteoclasts. Both enzymes 
have similar substrate speeificities,  but the restricted distri- 
bution of the 92-kD enzymes implies the requirement for the 
availability  of a  gene  transcribing  a  type  IV  collagenase 
(gelatinase)  for a more specific  purpose. 
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